ICAR – National Research Centre on Plant biotechnology (NRCPB) invited application from eligible candidates for 04 Project Associate and other posts. Eligible and Interested candidates can attend walk – in – interview along with application in the prescribed format & required copies of documents on 09 May 2016.
Under ICAR – NRCPB Recruitment 2016, out of total 05 posts, 01 post is for Research Associate, 02 posts for SRF and 02 posts for Young Professional – II.
Eligibility for Research Associate: Ph.D. Degree in Molecular Biology / Biotechnology / Life Sciences / allied sciences; or M.Sc. (Molecular Biology / Biotechnology / Life Sciences / allied sciences) with 4 years of Bachelor's degree. Candidates having post graduate degree in Basic Sciences with 3 years Bachelor's degree and 2 years Master's degree should have NET qualification.
Eligibility for Senior Research Fellow: M.Sc. (Molecular Biology / Biotechnology / Life Sciences / allied sciences) with 4 years of Bachelor's degree. Candidates having post graduate degree in Basic Sciences with 3 years Bachelor's degree and 2 years Master's degree should have NET qualification.
Eligibility for Young Professional – II Job 2016: Post graduate (M. Sc / M Tech) in Molecular Biology / Biotechnology /Agricultural Biotechnology / Life Sciences with specialization in plant molecular biology) with 60% marks or equivalent grade point average.
Eligible and Interested candidates can attend walk – in – interview along with application in the prescribed format & required copies of documents on 09 May 2016.
Click here for Detailed Notification
ICAR – NRCPB Recruitment 2016 for 05 Senior Research Fellow and Other Posts- Vacancy Details
ICAR – NRCPB Vacancy Details
- Research Associate – 01 post
- Senior Research Fellow – 02 posts
- Young Professional – II – 02 posts
Date of walk – in – interview: 09 May 2016
Maximum age limit for Research Associate, Senior Research Fellow and Yong Professional – II Jobs 2016
UR: 35 years.
SC / ST / OBC: 05 years maximum age relaxation.
.jpg)
Comments
All Comments (0)
Join the conversation